4//SEC Filing
Shankman Michael Elliot 4
Accession 0001348362-25-000007
CIK 0001348362other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:51 PM ET
Size
6.8 KB
Accession
0001348362-25-000007
Insider Transaction Report
Form 4
Shankman Michael Elliot
Chief Financial Officer
Transactions
- Award
Stock Options
2025-05-15+50,000→ 100,000 totalExercise: $1.04From: 2025-05-15Exp: 2030-05-15→ Common Shares (50,000 underlying)
Holdings
- 50,000
Stock Options
Exercise: $3.17From: 2025-02-28Exp: 2029-10-01→ Common Shares (50,000 underlying)
Footnotes (1)
- [F1]20,000 options are exercisable as of February 28, 2025, an additional 15,000 options are exercisable on August 31, 2025 and the remaining 15,000 options are exercisable on August 31, 2026
Documents
Issuer
Lexaria Bioscience Corp.
CIK 0001348362
Entity typeother
Related Parties
1- filerCIK 0002035175
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:51 PM ET
- Size
- 6.8 KB